MATHIEU, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 334.919
NA - Nord America 16.531
AS - Asia 6.654
SA - Sud America 1.204
Continente sconosciuto - Info sul continente non disponibili 727
AF - Africa 140
OC - Oceania 15
Totale 360.190
Nazione #
IT - Italia 330.031
US - Stati Uniti d'America 16.313
SG - Singapore 2.501
CN - Cina 2.366
UA - Ucraina 1.171
NL - Olanda 1.103
BR - Brasile 908
SE - Svezia 698
VN - Vietnam 685
FI - Finlandia 499
DE - Germania 428
GB - Regno Unito 366
FR - Francia 324
HK - Hong Kong 198
IN - India 153
KR - Corea 122
BD - Bangladesh 115
CA - Canada 111
AR - Argentina 103
TR - Turchia 73
IQ - Iraq 71
JP - Giappone 67
ID - Indonesia 57
RU - Federazione Russa 56
CO - Colombia 54
MX - Messico 46
EC - Ecuador 37
ES - Italia 37
BE - Belgio 35
PL - Polonia 29
VE - Venezuela 29
ZA - Sudafrica 28
PK - Pakistan 27
TN - Tunisia 23
UZ - Uzbekistan 23
CL - Cile 22
IR - Iran 22
MA - Marocco 22
IL - Israele 21
SA - Arabia Saudita 20
AT - Austria 18
EG - Egitto 18
PH - Filippine 16
CH - Svizzera 15
GR - Grecia 15
JO - Giordania 15
PE - Perù 15
PY - Paraguay 15
CZ - Repubblica Ceca 14
JM - Giamaica 14
KE - Kenya 13
BO - Bolivia 12
AU - Australia 11
DZ - Algeria 11
ET - Etiopia 11
OM - Oman 11
DK - Danimarca 10
IE - Irlanda 10
NP - Nepal 10
TT - Trinidad e Tobago 8
UY - Uruguay 8
BG - Bulgaria 7
BY - Bielorussia 7
HN - Honduras 7
MY - Malesia 7
PS - Palestinian Territory 7
AZ - Azerbaigian 6
GT - Guatemala 6
HR - Croazia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LT - Lituania 6
TH - Thailandia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DO - Repubblica Dominicana 5
LB - Libano 5
LU - Lussemburgo 5
EU - Europa 4
LK - Sri Lanka 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RO - Romania 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
GE - Georgia 3
KW - Kuwait 3
NI - Nicaragua 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
LC - Santa Lucia 2
MD - Moldavia 2
Totale 359.439
Città #
Cagliari 208.069
Uta 120.956
Fairfield 1.539
Woodbridge 1.338
Ashburn 1.267
Singapore 1.162
Amsterdam 1.072
Chandler 921
Houston 897
Dallas 869
San Jose 804
Ann Arbor 768
Boardman 725
Wilmington 646
Jacksonville 612
Seattle 558
Cambridge 494
Nyköping 462
Beijing 413
Dearborn 377
Council Bluffs 325
Helsinki 303
Los Angeles 273
Nanjing 208
Lauterbourg 199
Hefei 189
Ho Chi Minh City 182
Boston 181
Hong Kong 180
The Dalles 180
Santa Clara 173
Buffalo 159
Shanghai 145
New York 139
Dong Ket 128
Hanoi 121
Milan 116
Seoul 112
Redwood City 86
San Diego 86
Shenyang 83
Guangzhou 74
São Paulo 74
Nanchang 72
Rome 63
London 58
Hebei 52
Tianjin 52
Phoenix 51
Toronto 51
Chicago 50
Jiaxing 48
Changsha 46
Munich 45
Tokyo 44
Mountain View 42
Columbus 39
Verona 36
Sassari 35
Washington 35
Belo Horizonte 33
Norwalk 32
Baghdad 31
Brooklyn 31
Istanbul 31
Jinan 31
Orange 30
Redondo Beach 30
Atlanta 27
Brussels 26
Frankfurt am Main 26
Nuremberg 26
Orem 24
Auburn Hills 23
Falls Church 23
Warsaw 23
Da Nang 22
Kunming 21
Tashkent 21
Zhengzhou 21
Haiphong 20
Rio de Janeiro 20
San Mateo 20
Chennai 19
Denver 19
Stockholm 18
Detroit 17
Dhaka 17
Hải Dương 17
Mumbai 17
San Francisco 17
Buenos Aires 16
Montreal 16
Pune 16
Santiago 16
Florence 15
Ningbo 15
Hangzhou 14
Wuhan 14
Augusta 13
Totale 349.352
Nome #
Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology 118.828
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.756
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
An optimized infrastructure for deferred telemonitoring of home rehabilitation in chronic rheumatic patients 3.937
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.189
Home tele-rehabilitation for rheumatic patients: impact and satisfaction of care analysis 3.105
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.074
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 3.038
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.909
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.834
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.833
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.803
Apparatus, a system and a relating method for local or remote rehabilitation and functional evaluation of the hands 2.682
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.626
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.625
A Device for Local or Remote Monitoring of Hand Rehabilitation Sessions for Rheumatic Patients 2.617
Physical activity levels and health-related quality of life in young Italian population 2.416
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.365
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.348
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.348
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.300
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.291
Polymyalgia rheumatica: an autoinflammatory disorder? 2.247
null 2.245
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 2.216
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.186
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.183
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.180
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.140
An Integrated Portable Device for the Hand Functional Assessment in the Clinical Practice 2.119
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.117
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.101
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.080
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 2.038
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.989
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.977
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.964
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.960
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.946
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.938
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.924
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 1.858
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.818
A portable real-time monitoring system for kinesitherapic hand rehabilitation exercises 1.809
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.798
null 1.791
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.705
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 1.677
Does subclinical atherosclerosis really exist in systemic sclerosis? Comment on the article by Turiel et al. 1.666
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.664
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.646
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1.626
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.618
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 1.594
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.586
null 1.562
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 1.508
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.502
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.487
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 1.482
Genetics of Behcet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients 1.470
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.468
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.463
null 1.431
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 1.407
Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset 1.368
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes 1.337
Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy 1.317
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.270
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.262
Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a real-life setting 1.249
null 1.241
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.207
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.189
Vitamin D levels and potential impact in systemic sclerosis 1.135
Association between the presence of c-ANCA and abnormal cerebral single photon emission computed tomography (SPECT) in patients with systemic lupus erythematosus 1.120
Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease 1.085
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.071
The origin of Behçet’s disease geoepidemiology: possible role of a dual microbial - driven genetic selection. 1.070
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.061
Post-Streptococcal Reactive Arthritis Associated With Group G Streptococcal Pharyngitis 1.052
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 1.011
Multiple Septic Bursitis and Spontaneous Achilles Tendon Tear in Systemic Lupus Erythematosus 1.009
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 998
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice 996
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 985
Physical Activity Levels And Health-related Quality Of Life In Italian University Students 940
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 940
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 920
Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. 916
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 905
null 902
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 894
Calcitonin decreases lithium plasma levels in man. Preliminary report 888
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 886
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 863
Familial chilblain and late contractural arachnodactyly: A novel association? 860
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 858
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 852
Psoriatic arthritis: genetics and pathogenesis 838
Totale 300.746
Categoria #
all - tutte 453.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 453.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.576 0 907 666 639 911 893 729 683 1.203 1.008 1.486 1.451
2022/202316.051 1.637 1.842 1.641 1.235 1.471 1.550 715 2.097 1.095 926 1.127 715
2023/202423.751 1.187 772 885 1.656 2.156 3.234 3.323 3.923 982 1.467 2.304 1.862
2024/2025162.043 10.164 11.446 7.398 120.906 2.504 2.417 3.913 251 477 1.522 450 595
2025/202612.458 652 706 1.532 1.302 939 849 1.780 1.748 897 1.013 716 324
2026/2027887 495 392 0 0 0 0 0 0 0 0 0 0
Totale 360.190